Journal: mSphere
Article Title: Targeted metatranscriptomic detection of viruses from floors for simultaneous evaluation of respiratory disease burden and viral variant identification
doi: 10.1128/msphere.00086-26
Figure Lengend Snippet: ( A ) Bubble chart showing the normalized read abundances of samples collected between the final week of November (week 4) 2022 and the final week of February (week 4) 2023 for all detected viruses in each sample. Samples are colored and ordered according to date, and the size of the bubble corresponds to abundance of normalized reads. HWA, hallway A; HWB, hallway B; NTC, no template control; OWB, outside waiting room B; PC, positive control; TRI, triage; WRA, waiting room A; WRB, waiting room B (a mixture of SARS-CoV-2, RSV, and influenza virus RNA). ( B ) Histogram showing the number of samples each virus was detected in (out of 38 swab samples). Samples were normalized using a scaling approach; the median number of viral target reads across all samples (not including controls) was determined, and a scaling factor for each sample was calculated compared to this median. The scaling factor was applied to all viral read counts within that sample.
Article Snippet: Influenza A, influenza B, and SARS-CoV-2 synthetic RNA controls were obtained from Twist Bioscience (catalog numbers 103001, 103003, and 103907, respectively).
Techniques: Control, Positive Control, Virus